ArticleScientific reports2026
Conditional survival and prognostic nomogram for distant metastatic differentiated thyroid cancer after total thyroidectomy.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Adrenal metastases of differentiated thyroid cancer: clinicopathological characteristics and prognostic factors.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The long-term prognosis of patients with distant metastasis of differentiated thyroid cancer (DM-DTC) after total thyroidectomy remains poorly defined. This study aims to assess the conditional survival (CS) of DM-DTC patients following total thyroidectomy and to analyze the key prognostic factors, with the objective of developing a more accurate survival prediction tool for clinical application. We retrospectively analyzed data from patients diagnosed with DM-DTC who underwent total thyroidectomy between 2004 and 2019, retrieved from the Surveillance, Epidemiology, and End Results (SEER) database. Overall survival (OS) was estimated using the Kaplan-Meier method. CS rates were calculated using the formula CS(y/x) = OS(y + x)/OS(x), where CS(y/x) represents the probability of surviving an additional y years after already surviving x years. Prognostic factors were identified using the least absolute shrinkage and selection operator (LASSO) regression and incorporated into a CS-nomogram model developed through multivariate Cox regression. The CS-nomogram was validated, and predictive factors were assigned point values. A risk stratification system was subsequently established using the optimal threshold of the total score. A total of 1,235 patients with DM-DTC who underwent total thyroidectomy were included, with a median follow-up of 51 months. Kaplan-Meier survival analysis revealed 3-year, 5-year, and 10-year OS rates of 81.7%, 70.4%, and 46.9%, respectively. CS analysis demonstrated a progressive increase in survival rates over time. The 10-year cumulative survival rate increased from 46.9% to 51.1%, 54.4%, 57.5%, 61.5%, 66.7%, 72.3%, 79.6%, and 85.5%, ultimately reaching 93.5% after surviving 1 to 9 years. Prognostic factors identified through LASSO regression and multivariate Cox regression analysis included age, sex, histological type, tumor size, and radioactive iodine therapy. A novel CS-nomogram for dynamic real-time survival prediction was successfully developed and validated, enabling identification of high- and low-risk patient groups. This study represents the first evaluation of CS patterns in DM-DTC patients following total thyroidectomy, demonstrating a gradual improvement in postoperative survival rates over time. A novel CS-nomogram model was successfully developed and validated, offering clinicians a personalized, dynamic, and real-time survival prediction tool. The risk stratification system derived from this model effectively distinguishes high- and low-risk patients, providing valuable guidance for follow-up and risk assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.